Endothelial nitric oxide synthase gene polymorphisms and cardiovascular damage in hypertensive subjects: An Italian case-control study

被引：31

作者：

Colomba D. ^{[1
]}

Duro G. ^{[2
]}

Corrao S. ^{[1
]}

Argano C. ^{[1
]}

Di Chiara T. ^{[1
]}

Nuzzo D. ^{[2
]}

Pizzo F. ^{[2
]}

Parrinello G. ^{[1
]}

Scaglione R. ^{[1
]}

Licata G. ^{[1
]}

机构：

[1] Department of Internal Medicine, University of Palermo, Palermo

[2] Institute of Biomedicine and Molecular Immunology CNR, Palermo

来源：

Immunity & Ageing | / 5卷 / 1期

关键词：

Nitric Oxide; Target Organ Damage; Albumin Excretion Rate; eNOS Gene; Genotype Frequency Distribution;

D O I：

10.1186/1742-4933-5-4

中图分类号：

学科分类号：

摘要：

Background: Nitric oxide (NO) synthesized by endothelial nitric oxide synthase (eNOS) plays an important role in regulation of endothelial function and in the control of blood pressure. However, the results from some studies on the association between three clinically relevant eNOS gene polymorphisms (G894T, T786C and intron 4b/a) and essential hypertension are unclear. We designed a case-control study to evaluate the influence of eNOS polymorphisms on target organ damage in 127 hypertensives and 67 normotensives. Clinical evaluation, biochemical parameters, Urinary Albumin Excretion (UAE) and echocardiogram were performed to characterize target organ damage. eNOS polymorphism were recognized by PCR method. Results: The distribution of eNOS genotypes was similar in hypertensives and normotensives but 4aa was present in the 2.5% of hypertensives and completely absent in normotensives. Subjects with 4bb, G894T, and T786C genotypes showed an increased prevalence of target organ damage. Moreover prevalence of G894T and introne 4 variants was significantly higher in hypertensives than in normotensives both with cardiovascular damage. Logistic regression analysis didn't show any association between eNOS polymorphisms, Body Mass Index (BMI), hypertension, gender and cardiovascular damage. Only the age (OR 1.11; IC 95% 1.06-1.18) was predictive of cardiovascular damage in our population. Conclusion: Our results seem to indicate a lack of association with eNOS variants and cardiovascular damage onset. © 2008 Colomba et al; licensee BioMed Central Ltd.

引用

共 23 条

[1] Vallance P., Collier J., Moncada S., Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man, Lancet, 2, pp. 997-1000, (1989)
[2] Huang P.L., Huang Z., Mashimo H., Bloch K.D., Moskowitz M.A., Bevan J.A., Fishman M.C., Hypertension in mice lacking the gene for endothelial nitric oxide synthase, Nature, 377, pp. 239-242, (1995)
[3] Haynes W.G., Noon J.P., Walker B.R., Webb D.J., Inhibition of nitric oxide synthesis increases blood pressure in healthy humans, J Hypertens, 11, pp. 1375-1380, (1993)
[4] Forte P., Copland M., Smith L.M., Milne E., Sutherland J., Benjamin N., Basal nitric oxide synthesis in essential hypertension, Lancet, 349, pp. 837-842, (1997)
[5] Zintzaras E., Gergios K., Stefanidis I., Endotelial NO Synthase Gene Polymorphisms and Hypertension, Hypertension, 48, pp. 1-11, (2006)
[6] Asakimori Y., Yorioka N., Tanaka J., Takasugi N., Harada S., Shigemoto K., Yamashita K., Usui K., Arita M., Kohno N., Association between ENOS gene polymorphism and cardiovascular events in nondiabetic hemodialysis patients: A prospective study, Am J Kidney Dis, 44, pp. 112-120, (2004)
[7] Karvonen J., Kauma H., Kervinen K., Rantala M., Ikaheimo M., Paivansalo M., Savolainen M.J., Kesaniemi Y.A., Endothelial nitric oxide synthase gene Glu298Asp polymorphism and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population-based cohort, J Intern Med, 251, pp. 102-110, (2002)
[8] Lacolley P., Gautier S., Poirier O., Pannier B., Cambien F., Benetos A., Nitric oxide synthase gene polymorphisms, blood pressure and aortic stiffness in normotensive and hypertensive subjects, J Hypertens, 16, pp. 31-35, (1998)
[9] Miyamoto Y., Saito Y., Kajiyama N., Yoshimura M., Shimasaki Y., Nakayama M., Kamitani S., Harada M., Ishikawa M., Kuwahara K., Ogawa E., Hamanaka I., Takahashi N., Kaneshige T., Teraoka H., Akamizu T., Azuma N., Yoshimasa Y., Yoshimasa T., Itoh H., Masuda I., Yasue H., Nakao K., Endothelial nitric oxide synthase gene is positively associated with essential hypertension, Hypertension, 32, pp. 3-8, (1998)
[10] Kato N., Sugiyama T., Morita H., Nabika T., Kurihara H., Yamori Y., Yazaki Y., Lack of evidence for association between the endothelial nitric oxide synthase gene and hypertension, Hypertension, 33, pp. 933-936, (1999)

← 1 2 3 →